Molecular dissection of dopamine receptor signaling

Journal of Chemical Neuroanatomy

Volumn 23, Issue 4, 2002, Pages 237-242

  Hiroi, Noboru ^a   Martín, Ana B ^b   Grande, Cristina ^b   Alberti, Israel ^b   Rivera, Alicia ^b   Moratalla, Rosario ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Catalepsy; D1; D2; Enkephalin; Fos; Haloperidol

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ENKEPHALIN; HALOPERIDOL; PROTEIN C FOS; RACLOPRIDE; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; BEHAVIOR; CATALEPSY; CELL ASSAY; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ACTIVITY; DRUG RESPONSE; GENE DELETION; GENE TARGETING; GENETIC ANALYSIS; GLOBUS PALLIDUS; KNOCKOUT MOUSE; MOUSE; NERVE PROJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, DOPAMINE D1; SIGNAL TRANSDUCTION;

EID: 0036283849     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(02)00010-8     Document Type: Conference Paper

References (37)

1. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated
2. Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields
3. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons
4. Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain
5. The neostriatal mosaic: Multiple levels of compartmental organization
6. Basal ganglia - Input, neural activity, and relation to the cortex
7. Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain: Contrasting targets of haloperidol and clozapine
8. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum
9. FosB mutant mice: Loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects
10. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation
11. Dopamine receptors and brain function
12. Differential expression of inducible transcription factors in basal ganglia neurons
13. Striatal c-fos levels do not correlate with haloperidol-induced behavioral supersensitivity
14. Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol
15. Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs
16. Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice
17. Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor
18. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal
19. Coordinate expression of c-fos and jun B in the rat striatum by cocaine
20. Genes and addiction
21. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine
22. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine
23. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons
24. Molecular biology of dopamine receptors
25. Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context
26. Structure and function of dopamine receptors
27. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects
28. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain
29. Scopolamine augments c-fos and ZIF/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-82958 in the intact rat striatum
30. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine
31. Functional and pathophysiological models of the basal ganglia
32. D1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja
33. Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum
34. Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D(1) dopamine receptors in the rat
35. Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats
36. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses
37. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice